LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 5.36 | 27.76 | 680 | 320 | 2.1226 | 1.4755 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 5.36 | 27.76 | 776 | 320 | 2.4223 | 1.5699 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 7.06 | 27.76 | 694 | 360 | 1.9278 | 1.3886 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 7.06 | 27.76 | 750 | 360 | 2.0833 | 1.4392 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 7.06 | 27.76 | 872 | 360 | 2.4222 | 1.5407 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 8.76 | 27.76 | 2 | 401 | 0.0050 | -0.4947 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 8.76 | 27.76 | 744 | 401 | 1.8547 | 1.3478 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 8.76 | 27.76 | 2 | 401 | 0.0050 | -0.4947 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 8.76 | 27.76 | 840 | 401 | 2.0940 | 1.4229 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 8.76 | 27.76 | 2 | 401 | 0.0050 | -0.4947 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 8.76 | 27.76 | 969 | 401 | 2.4156 | 1.5144 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 10.46 | 27.76 | 2 | 438 | 0.0046 | -0.4834 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 10.46 | 27.76 | 799 | 438 | 1.8215 | 1.3251 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 10.46 | 27.76 | 2 | 438 | 0.0046 | -0.4834 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 10.46 | 27.76 | 908 | 438 | 2.0700 | 1.4009 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 10.46 | 27.76 | 14 | 438 | 0.0319 | -0.1579 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 10.46 | 27.76 | 1045 | 438 | 2.3823 | 1.4872 | MN20160318_Q01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 12.17 | 27.76 | 5 | 489 | 0.0102 | -0.3391 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 12.17 | 27.76 | 848 | 489 | 1.7339 | 1.2844 | MN20160318_Q01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 12.17 | 27.76 | 3 | 489 | 0.0061 | -0.4158 | MN20160318_Q01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 12.17 | 27.76 | 926 | 489 | 1.8934 | 1.3335 | MN20160318_Q01 | H12 |